Cancer Biology & Therapy

Papers
(The TQCC of Cancer Biology & Therapy is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA1874
Targeting mitochondrial tyrosyl-tRNA synthetase YARS2 suppresses colorectal cancer progression38
Loading of ”cocktail siRNAs” into extracellular vesicles via TAT-DRBD peptide for the treatment of castration-resistant prostate cancer33
MMP1 regulated by NEAT1/miR-361-5p axis facilitates the proliferation and migration of cutaneous squamous cell carcinoma via the activation of Wnt pathway29
Effect of extracellular vesicle ZNF280B derived from lung cancer stem cells on lung cancer progression27
NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA24
BRD4 PROTAC degrader MZ1 exerts anticancer effects in acute myeloid leukemia by targeting c-Myc and ANP32B genes24
LINC00668 cooperated with HuR dependent upregulation of PKN2 to facilitate gastric cancer metastasis23
Deep and lasting response and acquired resistance to BRAFV600E targeting in a low-grade ovarian cancer patient22
Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article22
CX43 down-regulation promotes cell aggressiveness and 5-fluorouracil-resistance by attenuating cell stiffness in colorectal carcinoma22
Cancer-associated fibroblasts derived extracellular vesicles promote angiogenesis of colorectal adenocarcinoma cells through miR-135b-5p/FOXO1 axis22
YY1-inudced activation of lncRNA DUXAP8 promotes proliferation and suppresses apoptosis of triple negative breast cancer cells through upregulating SAPCD221
Biguanide drugs enhance cytotoxic effects of cisplatin by depleting aspartate and NAD+ in sensitive cancer cells20
Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells18
Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma18
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis17
The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis17
Personalized functional profiling using ex-vivo patient-derived spheroids points out the potential of an antiangiogenic treatment in a patient with a metastatic lung atypical carcinoid17
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway17
hsa_circ_0020378 regulating miR-339-3p/COL1A1 promotes osteosarcoma progression17
Silencing of LINC00284 inhibits cell proliferation and migration in oral squamous cell carcinoma by the miR-211-3p/MAFG axis and FUS/KAZN axis16
Ruangan Lidan decoction inhibits the growth and metastasis of liver cancer by downregulating miR-9-5p and upregulating PDK416
Interleukin-2, Ipilimumab, and Anti-PD-1: clinical management and the evolving role of immunotherapy for the treatment of patients with metastatic melanoma16
Identification of USP29 as a key regulator of nucleotide biosynthesis in neuroblastoma through integrative analysis of multi-omics data16
Correction15
Expression and clinical significance of NLRC5 in hepatocellular carcinoma15
Correction15
CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells15
Mutually exclusive teams-like patterns of gene regulation characterize phenotypic heterogeneity along the noradrenergic-mesenchymal axis in neuroblastoma14
Significant response to pembrolizumab plus lenvatinib in Epstein–Barr-virus-associated intrahepatic cholangiocarcinoma: a case report14
Agent-based modeling in cancer biomedicine: applications and tools for calibration and validation14
The effects of Aurora Kinase inhibition on thyroid cancer growth and sensitivity to MAPK-directed therapies13
Immunotherapy resistance in solid tumors: mechanisms and potential solutions13
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers13
Natural killer cell memory: challenges and opportunities for cancer immunotherapy13
CircSETD2 inhibits YAP1 by interaction with HuR during breast cancer progression13
RND1 inhibits epithelial-mesenchymal transition and temozolomide resistance of glioblastoma via AKT/GSK3-β pathway13
Daurisoline inhibits glycolysis of lung cancer by targeting the AKT-HK2 axis13
Carcinoma-associated fibroblasts release microRNA-331-3p containing extracellular vesicles to exacerbate the development of pancreatic cancer via the SCARA5-FAK axis13
LncRNA FGD5-AS1 accelerates cell proliferation in pancreatic cancer by regulating miR-520a-3p/KIAA1522 axis12
Targeted FGFR/VEGFR/PDGFR inhibition with dovitinib enhances the effects of nab-paclitaxel in preclinical gastric cancer models12
PLK4 inhibitor exhibits antitumor effect and synergizes sorafenib via arresting cell cycle and inactivating Wnt/β-catenin pathway in anaplastic thyroid cancer12
The function and mechanism of the JARID2/CCND1 axis in modulating glioma cell growth and sensitivity to temozolomide (TMZ)12
Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance12
TRIM55 suppresses malignant biological behavior of lung adenocarcinoma cells by increasing protein degradation of Snail112
WYC-209 inhibited GC malignant progression by down-regulating WNT4 through RARα12
Challenges documenting racial disparities in Merkel cell carcinoma12
Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay11
The human microbiome and cancer: a diagnostic and therapeutic perspective11
Single whole genome sequencing analysis blazes the trail for precision medicine11
Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells11
Correction10
eIf3a mediates malignant biological behaviors in colorectal cancer through the PI3K/AKT signaling pathway10
NAALADL2-AS2 functions as a competing endogenous RNA to regulate apoptosis and drug resistance in DLBCL10
EGR1/ LINC00839 /SOX5 axis modulates migration, invasion and Gemcitabine resistance of bladder cancer cells10
Whole-genome sequencing reveals cellular origin of concomitant chronic lymphocytic leukemia and multiple myeloma: a case report10
Function of m 5 C RNA methyltransferase NOP2 in high-grade serous ovarian cancer10
EX527, a sirtuins 1 inhibitor, sensitizes T-cell leukemia to death receptor-mediated apoptosis by downregulating cellular FLICE inhibitory protein10
Feasibility and safety of targeting mitochondria for cancer therapy – preclinical characterization of gamitrinib, a first-in-class, mitochondriaL-targeted small molecule Hsp90 inhibitor9
Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition9
Transcription factor KLF2 enhances the sensitivity of breast cancer cells to cisplatin by suppressing kinase WEE19
Evaluating massage therapy for radiation-induced fibrosis in rats: preliminary findings and palpation results9
Serum ferritin level is an effective prognostic factor for lung cancer immunotherapy8
Oxygen and metabolic reprogramming in the tumor microenvironment influences metastasis homing8
LncRNA TM4SF19-AS1 exacerbates cell proliferation, migration, invasion, and EMT in head and neck squamous cell carcinoma via enhancing LAMC1 expression8
Comparison of tumor growth assessment using GFP fluorescence and DiI labeling in a zebrafish xenograft model8
A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis8
Real-time luminescence enables continuous drug–response analysis in adherent and suspension cell lines8
Phase II study of apatinib plus exemestane in estrogen receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer8
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer8
Inhibitors of Jumonji C domain-containing histone lysine demethylases overcome cisplatin and paclitaxel resistance in non-small cell lung cancer through APC/Cdh1-dependent degradation of CtIP and PAF18
A study on metabolic characteristics and metabolic markers of gastrointestinal tumors8
MiR-133b suppresses the proliferation, migration and invasion of lung adenocarcinoma cells by targeting SKA38
N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker8
TP53 mutation detected in circulating exosomal DNA is associated with prognosis of patients with hepatocellular carcinoma8
NVP-2, in combination with Orlistat, represents a promising therapeutic strategy for acute myeloid leukemia7
Lutetium-177-PSMA-617: A Vision of the Future7
Evaluation of microRNAs as potential biomarkers in circulating HPV-DNA-positive non-small cell lung cancer patients7
NSUN6, an RNA methyltransferase of 5-mC controls glioblastoma response to temozolomide (TMZ) via NELFB and RPS6KB2 interaction7
The impact of radiation dose on the efficacy of definitive chemoradiotherapy in patients with locally advanced esophageal carcinoma: a systematic review and meta-analysis7
Angiotensin receptor blockade and stereotactic body radiation therapy for early stage lung cancer ARB & SBRT for early stage lung cancer7
CAFs-derived small extracellular vesicles circN4BP2L2 promotes proliferation and metastasis of colorectal cancer via miR-664b-3p/HMGB3 pathway7
Graphene quantum dots mediated magnetic chitosan drug delivery nanosystems for targeting synergistic photothermal-chemotherapy of hepatocellular carcinoma7
Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature7
The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development7
0.094998121261597